Vasoactive intestinal peptide exerts therapeutic action by regulating PTEN in a model of Sjögren's disease
Abstract Introduction Sjögren's disease (SjD) is a chronic autoimmune disease characterized by the loss of the secretory function of the exocrine glands. At present, drugs that can both correct the immune imbalance and improve exocrine gland function are needed. Meanwhile, vasoactive intestinal...
Saved in:
| Main Authors: | Yixi Li, Wen Zhu, Rui Lin, Junjie Zhao, Yue Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-07-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.936 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic diarrhea related to neuroblastoma: the important role of vasoactive intestinal peptide in tumor pathology and survival
by: Meng-ying Cao, et al.
Published: (2025-03-01) -
Vasoactive intestinal polypeptide level in gastroesophageal reflux disease before and after surgical treatment
by: Ye. I. Haidarzhi, et al.
Published: (2023-07-01) -
Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma
by: Josy Thomas, et al.
Published: (2024-11-01) -
Serum Vasoactive Intestinal Peptide as a Novel Biomarker for Low‐Voltage Areas in Patients With Atrial Fibrillation
by: Kotaro Nishino, et al.
Published: (2025-04-01) -
The level of vasoactive intestinal polypeptide in patients with hypothyroidism and impaired intestinal function, and its association with markers of visceral hypersensitivity
by: V.H. Mishchuk, et al.
Published: (2025-06-01)